Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Electronic Advice Request System for Nephrology in Alberta: Pilot Results and Implementation.

Bello AK, Zaidi D, Braam B, Chou S, Courtney M, Deved V, Glassford J, Jindal K, Klarenbach S, Osman M, Scott-Douglas N, Shurraw S, Thompson S, Manns B, Hemmelgarn B, Tonelli M.

Can J Kidney Health Dis. 2019 Oct 4;6:2054358119879778. doi: 10.1177/2054358119879778. eCollection 2019.

2.

Protocol: Improving Access to Specialist Nephrology Care Among Rural/Remote Dwellers of Alberta: The Role of Electronic Consultation in Improving Care for Patients With Chronic Kidney Disease.

Bello A, Zaidi D, Braam B, Courtney M, Glassford J, Jindal K, Klarenbach S, Kurzawa J, Osman M, Scott-Douglas N, Szigety S, Thompson S, Manns B, Hemmelgarn B, Tonelli M.

Can J Kidney Health Dis. 2019 Sep 30;6:2054358119878715. doi: 10.1177/2054358119878715. eCollection 2019.

3.

Can economic incentives increase the use of home dialysis?

Manns B, Agar JWM, Biyani M, Blake PG, Cass A, Culleton B, Kleophas W, Komenda P, Lobbedez T, MacRae J, Marshall MR, Scott-Douglas N, Srivastava V, Magner P.

Nephrol Dial Transplant. 2019 May 1;34(5):731-741. doi: 10.1093/ndt/gfy223.

PMID:
30010852
4.

Effectiveness and Cost of Weekly Recombinant Tissue Plasminogen Activator Hemodialysis Catheter Locking Solution.

Hemmelgarn BR, Manns BJ, Soroka SD, Levin A, MacRae J, Tennankore K, Wilson JS, Weaver RG, Ravani P, Quinn RR, Tonelli M, Kiaii M, Mossop P, Scott-Douglas N.

Clin J Am Soc Nephrol. 2018 Mar 7;13(3):429-435. doi: 10.2215/CJN.08510817. Epub 2018 Jan 15.

5.

Disparity between Nephrologists' Opinions and Contemporary Practices for Community Follow-Up after AKI Hospitalization.

Karsanji DJ, Pannu N, Manns BJ, Hemmelgarn BR, Tan Z, Jindal K, Scott-Douglas N, James MT.

Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1753-1761. doi: 10.2215/CJN.01450217. Epub 2017 Oct 12.

6.

Trends in the Management of Patients With Kidney Failure in Alberta, Canada (2004-2013).

Chong CC, Tam-Tham H, Hemmelgarn BR, Weaver RG, Scott-Douglas N, Tonelli M, Quinn RR, Manns L, Manns BJ.

Can J Kidney Health Dis. 2017 Mar 22;4:2054358117698668. doi: 10.1177/2054358117698668. eCollection 2017.

7.

Patient, family physician and community pharmacist perspectives on expanded pharmacy scope of practice: a qualitative study.

Donald M, King-Shier K, Tsuyuki RT, Al Hamarneh YN, Jones CA, Manns B, Tonelli M, Tink W, Scott-Douglas N, Hemmelgarn BR.

CMAJ Open. 2017 Mar 6;5(1):E205-E212. doi: 10.9778/cmajo.20160135. eCollection 2017 Jan-Mar.

8.

A Population-Based Analysis of Quality Indicators in CKD.

Manns L, Scott-Douglas N, Tonelli M, Weaver R, Tam-Tham H, Chong C, Hemmelgarn B.

Clin J Am Soc Nephrol. 2017 May 8;12(5):727-733. doi: 10.2215/CJN.08720816. Epub 2017 Apr 4.

9.

Potentially Preventable Hospitalization among Patients with CKD and High Inpatient Use.

Ronksley PE, Hemmelgarn BR, Manns BJ, Wick J, James MT, Ravani P, Quinn RR, Scott-Douglas N, Lewanczuk R, Tonelli M.

Clin J Am Soc Nephrol. 2016 Nov 7;11(11):2022-2031. Epub 2016 Oct 6.

10.

Development and implementation of an online clinical pathway for adult chronic kidney disease in primary care: a mixed methods study.

Donald M, McBrien K, Jackson W, Manns BJ, Tonelli M, King-Shier K, Jindal K, Lewanczuk RZ, Scott-Douglas N, Braun T, Straus SE, Naugler C, Elliott MJ, Jun M, Hemmelgarn BR.

BMC Med Inform Decis Mak. 2016 Aug 17;16:109. doi: 10.1186/s12911-016-0350-z.

11.

Citrate vs. acetate dialysate on intradialytic heparin dose: A double blind randomized crossover study.

Leung KC, Tai DJ, Ravani P, Quinn RR, Scott-Douglas N, MacRae JM.

Hemodial Int. 2016 Oct;20(4):537-547. doi: 10.1111/hdi.12433. Epub 2016 Jun 20.

PMID:
27325599
12.

The effect of citrate dialysate on intradialytic heparin dose in haemodialysis patients: study design of a randomised controlled trial.

Tai DJ, Leung K, Ravani P, Quinn RR, Scott-Douglas N, MacRae JM; Alberta Kidney Disease Network.

BMC Nephrol. 2015 Aug 25;16:147. doi: 10.1186/s12882-015-0144-z.

13.

An economic evaluation of rt-PA locking solution in dialysis catheters.

Manns BJ, Scott-Douglas N, Tonelli M, Ravani P, LeBlanc M, Dorval M, Holden R, Moist L, Lok C, Zimmerman D, Au F, Hemmelgarn BR.

J Am Soc Nephrol. 2014 Dec;25(12):2887-95. doi: 10.1681/ASN.2013050463. Epub 2014 Jul 10.

14.

Improving prevention, early recognition and management of acute kidney injury after major surgery: results of a planning meeting with multidisciplinary stakeholders.

James MT, Dixon E, Roberts DJ, Barry R, Balint C, Bharwani A, Buie WD, Godinez T, Hemmelgarn BR, Kortbeek JB, Manns BJ, Marin A, Scott-Douglas N, Stelfox HT, Pannu N.

Can J Kidney Health Dis. 2014 Aug 26;1:20. doi: 10.1186/s40697-014-0020-y. eCollection 2014.

15.

Risk factors associated with hemodialysis central venous catheter malfunction; a retrospective analysis of a randomized controlled trial.

Ward DR, Moist LM, MacRae JM, Scott-Douglas N, Zhang J, Tonelli M, Lok CE, Soroka SD, Hemmelgarn BR.

Can J Kidney Health Dis. 2014 Jul 8;1:15. doi: 10.1186/2054-3581-1-15. eCollection 2014.

16.

Assessment of the Siksika chronic disease nephropathy-prevention clinic.

Ward DR, Novak E, Scott-Douglas N, Brar S, White M, Hemmelgarn BR.

Can Fam Physician. 2013 Jan;59(1):e19-25.

17.

Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm.

Skali H, Lin J, Pfeffer MA, Chen CY, Cooper ME, McMurray JJ, Nissenson AR, Remuzzi G, Rossert J, Parfrey PS, Scott-Douglas NW, Singh AK, Toto R, Uno H, Ivanovich P.

Am J Kidney Dis. 2013 Feb;61(2):238-46. doi: 10.1053/j.ajkd.2012.08.043. Epub 2012 Nov 16.

PMID:
23159232
18.

Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator.

Hemmelgarn BR, Moist LM, Lok CE, Tonelli M, Manns BJ, Holden RM, LeBlanc M, Faris P, Barre P, Zhang J, Scott-Douglas N; Prevention of Dialysis Catheter Lumen Occlusion with rt-PA versus Heparin Study Group.

N Engl J Med. 2011 Jan 27;364(4):303-12. doi: 10.1056/NEJMoa1011376.

19.

Warfarin: safe in dialysis patients with atrial fibrillation?

Quinn RR, Scott-Douglas N.

Nat Rev Nephrol. 2010 Jan;6(1):17-8. doi: 10.1038/nrneph.2009.212. No abstract available.

PMID:
20023687
20.

Overview of the Alberta Kidney Disease Network.

Hemmelgarn BR, Clement F, Manns BJ, Klarenbach S, James MT, Ravani P, Pannu N, Ahmed SB, MacRae J, Scott-Douglas N, Jindal K, Quinn R, Culleton BF, Wiebe N, Krause R, Thorlacius L, Tonelli M.

BMC Nephrol. 2009 Oct 19;10:30. doi: 10.1186/1471-2369-10-30.

21.

Adrenal vein sampling may not be a gold-standard diagnostic test in primary aldosteronism: final diagnosis depends upon which interpretation rule is used. Variable interpretation of adrenal vein sampling.

Kline GA, Harvey A, Jones C, Hill MH, So B, Scott-Douglas N, Pasieka JL.

Int Urol Nephrol. 2008;40(4):1035-43. doi: 10.1007/s11255-008-9441-9. Epub 2008 Aug 12.

PMID:
18696249
22.

Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial.

Culleton BF, Walsh M, Klarenbach SW, Mortis G, Scott-Douglas N, Quinn RR, Tonelli M, Donnelly S, Friedrich MG, Kumar A, Mahallati H, Hemmelgarn BR, Manns BJ.

JAMA. 2007 Sep 19;298(11):1291-9.

PMID:
17878421
23.

Concentration of heparin-locking solution and risk of central venous hemodialysis catheter malfunction.

Thomas CM, Zhang J, Lim TH, Scott-Douglas N, Hons RB, Hemmelgarn BR; Alberta Kidney Disease Network.

ASAIO J. 2007 Jul-Aug;53(4):485-8.

PMID:
17667236
24.

Prevention of catheter lumen occlusion with rT-PA versus heparin (Pre-CLOT): study protocol of a randomized trial [ISRCTN35253449].

Hemmelgarn BR, Moist L, Pilkey RM, Lok C, Dorval M, Tam PY, Berall MJ, LeBlanc M, Toffelmire EB, Manns BJ, Scott-Douglas N; Canadian Hemodialysis Catheter Working Group.

BMC Nephrol. 2006 Apr 11;7:8.

25.

Effects of folinic acid on forearm blood flow in patients with end-stage renal disease.

Anderson TJ, Sun YH, Hubacek J, Hyndman ME, Verma S, Shewchuk L, Scott-Douglas N.

Nephrol Dial Transplant. 2006 Jul;21(7):1927-33. Epub 2006 Mar 6.

PMID:
16520350
26.

Lamivudine for the treatment of membranous glomerulopathy secondary to chronic Hepatitis B infection.

Gan SI, Devlin SM, Scott-Douglas NW, Burak KW.

Can J Gastroenterol. 2005 Oct;19(10):625-9. Review.

PMID:
16247526
27.

Resolution of thrombotic microangiopathy following renal transplant.

Heemskerk L, Scott-Douglas N, Yilmaz S, McLaughlin K.

Nephrol Dial Transplant. 2005 Mar;20(3):639-41. No abstract available.

PMID:
15735247
29.

Effects of acute volume loading and hemorrhage on intestinal vascular capacitance: a mechanism whereby capacitance modulates cardiac output.

Scott-Douglas NW, Robinson VJ, Smiseth OA, Wright CI, Manyari DE, Smith ER, Tyberg JV.

Can J Cardiol. 2002 May;18(5):515-22.

PMID:
12032578
30.

Oral vitamin B(12) and high-dose folic acid in hemodialysis patients with hyper-homocyst(e)inemia.

Manns B, Hyndman E, Burgess E, Parsons H, Schaefer J, Snyder F, Scott-Douglas N.

Kidney Int. 2001 Mar;59(3):1103-9.

31.

Arterial versus venous changes in vascular capacitance during nitroprusside infusion: a vascular modelling study.

Wang SY, Scott-Douglas NW, Manyari DE, Tyberg JV.

Can J Physiol Pharmacol. 1999 Feb;77(2):131-7.

PMID:
10535704
32.

Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease.

Manns BJ, Burgess ED, Hyndman ME, Parsons HG, Schaefer JP, Scott-Douglas NW.

Am J Kidney Dis. 1999 Oct;34(4):669-77.

PMID:
10516348
33.

Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients.

Manns BJ, Burgess ED, Parsons HG, Schaefer JP, Hyndman ME, Scott-Douglas NW.

Kidney Int. 1999 Jan;55(1):315-20.

34.

Treatment of acute renal transplant rejection with FK 506 in patients on cyclosporine after failure of standard antirejection therapy.

Scott-Douglas N, Zimmerman D, Klassen J.

Transplant Proc. 1996 Dec;28(6):3165. No abstract available.

PMID:
8962226
35.

Splanchnic venous pressure-volume relation during experimental acute ischemic heart failure. Differential effects of hydralazine, enalaprilat, and nitroglycerin.

Wang SY, Manyari DE, Scott-Douglas N, Smiseth OA, Smith ER, Tyberg JV.

Circulation. 1995 Feb 15;91(4):1205-12.

PMID:
7850960
36.

Measurement of intestinal vascular capacitance in dogs: an application of blood pool scintigraphy.

Scott-Douglas NW, Manyari DE, Smiseth OA, Robinson VJ, Wang SY, Smith ER, Tyberg JV.

J Appl Physiol (1985). 1995 Jan;78(1):232-8.

PMID:
7713818
37.

The veins and ventricular preload.

Tyberg JV, Scott-Douglas NW, Wang Y, Manyari DE.

Adv Exp Med Biol. 1993;346:313-7. Review. No abstract available.

PMID:
8184771
38.

Abdominal compressions during CPR: hemodynamic effects of altering timing and force.

Christenson JM, Hamilton DR, Scott-Douglas NW, Tyberg JV, Powell DG.

J Emerg Med. 1992 May-Jun;10(3):257-66.

PMID:
1624736
39.

The right and left ventricular intracavitary and transmural pressure-strain relationships.

Traboulsi M, Scott-Douglas NW, Smith ER, Tyberg JV.

Am Heart J. 1992 May;123(5):1279-87.

PMID:
1575146
40.

Experimental instrumentation and left ventricular pressure-strain relationship.

Scott-Douglas NW, Traboulsi M, Smith ER, Tyberg JV.

Am J Physiol. 1991 Dec;261(6 Pt 2):H1693-7.

PMID:
1750527
41.

The effect of nitroglycerin on pulmonary vascular capacitance in dogs.

Smiseth OA, Manyari DE, Scott-Douglas NW, Wang Y, Kingma I, Smith ER, Tyberg JV.

Am Heart J. 1991 May;121(5):1454-9.

PMID:
1902053
42.

Assessment of the splanchnic vascular capacity and capacitance using quantitative equilibrium blood-pool scintigraphy.

Robinson VJ, Smiseth OA, Scott-Douglas NW, Smith ER, Tyberg JV, Manyari DE.

J Nucl Med. 1990 Feb;31(2):154-9.

43.
44.

Modulation of vascular capacitance by angiotensin and nitroprusside: a mechanism of changes in pericardial pressure.

Smiseth OA, Manyari DE, Lima JA, Scott-Douglas NW, Kingma I, Smith ER, Tyberg JV.

Circulation. 1987 Oct;76(4):875-83.

PMID:
3652426
45.

Nonuniformity of pericardial surface pressure in dogs.

Smiseth OA, Scott-Douglas NW, Thompson CR, Smith ER, Tyberg JV.

Circulation. 1987 Jun;75(6):1229-36.

PMID:
3568329

Supplemental Content

Loading ...
Support Center